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ABSTRACT  
Topiramate (sulfamate-substituted monosaccharide) is a broad spectrum newer anti-convulsant. It is also used in prophylaxis of migraine, 
cluster headache, bipolar affective disorder, post traumatic stress disorder, post herpetic neuralgia, relapse prevention in alcohol 
dependence syndrome, add on treatment for antipsychotic induced weight gain. Acute Myopia and angle closure glaucoma are some of 
the rare side effects of topiramate. This case highlights the development of myopia in a middle aged patient with alcohol dependence 
syndrome while he was on topiramate therapy.  
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INTRODUCTION 
Topiramate is a sulfamate substituted monosaccharide, a broad 
spectrum anticonvulsant acting on voltage dependent sodium 
channels, enhancement of gamma amino butyric acid (GABA), 
decrease in glutamate and inhibition of carbonic anhydrase. We 
(the psychiatrists) use topiramate to treat migraine, cluster 
headache, bipolar affective disorder, post traumatic stress 
disorder, post herpetic neuralgia, relapse prevention in alcohol 
dependence syndrome, add on treatment for antipsychotic 
induced weight gain[1]. Some of the rare side effects of 
topiramate are acute myopia and angle closure glaucoma. There 
have been rare reports of acute myopia with or without 
secondary angle closure glaucoma in adults and children 
receiving topiramate[2], [3]. We report a case of topiramate 
induced transient myopia in a patient who had been started on 
topiramate for relapse prevention in alcohol dependence 
syndrome.  
CASE REPORT 
A 35 year old married male, lower middle socio economic status 
from rural background, working in a private company presented 
to the outpatient services of our department of psychiatry with 
10 years history of alcohol use amounting to dependence and 
two weeks history of blurred vision and headache. Patient was 
diagnosed as a case of alcohol dependence syndrome – 
uncomplicated withdrawal state (F10.30) as per International 
Classification of Diseases (ICD) -10 criteria. He was admitted 
for detoxification and on eliciting history; it was found that he 
had been commenced on oral topiramate 50 mg/day 3 weeks 
previously by a private psychiatrist for his alcohol use. The 
patient had no history of hypertension, diabetes or glaucoma, he 
had never worn glasses and there was no history of injury to eyes 
or head and no history of withdrawal seizures. He was referred 
to department of ophthalmology for blurred vision. Ophthalmic 
opinion on the day of admission suggested refractive errors 
bilaterally with left eye myopia of -2.5 diopters and right eye 
myopia of -3.5 diopters with shallow anterior chamber and 
normal pupils and lens on slit lamp examination and normal 
intra ocular pressure on tonometry. After this ophthalmologic 
report, topiramate was stopped immediately by us thinking that 
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it could have induced myopia. Other routine investigations were 
normal and detoxification with oral lorazepam and thiamine 
supplementation continued along with motivation enhancement 
sessions by psychologist. Patient reported gradual clinical 
improvement in his vision. Repeat ophthalmologic consultation 
on the 7th day of admission showed significant improvement in 
visual acuity and refraction with left eye - myopia of 0.75 
diopters and right eye - myopia of 0.75 diopters. Because of our 
early intervention, angle closure glaucoma was averted in our 
case. 
DISCUSSION  
The most frequently reported side effects for Topiramote are 
dizziness, mental slowing, somnolence, ataxia, impaired 
concentration and confusion[4]. Most of these are transient and 
observed during the initial weeks of therapy and can be reduced 
by slow titration of the dose. Anorexia and mild weight loss has 
been observed during the therapy. Metabolic acidosis, and 
nephrolithiasis are the other reported side effects. WHO 
Causality assessment [5] suggests abnormal vision, acute 
secondary angle closure glaucoma, acute myopia and 
suprachoroidal effusions are complications of Topiramate 
therapy.  This case highlights and aims to raise awareness that 
topiramate can cause acute myopia and angle closure glaucoma. 
Both are reversible with immediate discontinuation of the 
drug[6]. Various authors have also reported these serious 
complications due to topiramate[6 - 8, 2 & 3]. The mechanism for 
topiramate induced angle closure glaucoma is by ciliochoroidal 
effusion with forward displacement of the lens – iris diaphragm 
and anterior chamber shallowing, resulting in acute myopia and 
angle closure glaucoma[6]. Topiramate has been reported to 
cause choroidal effusions, thereby antieriorly rotating the ciliary 
body and causing an angle closure glaucoma[9]. Topiramate’s 
weak carbonic anhydrase inhibitor activity and prostaglandin 
mediated effects have also been postulated as possible 
mechanisms[10]. Acute myopia up to -9.0 diopters can occur in a 
matter of hours after starting topiramate, but might take weeks 
to fully resolve. Another study says onset of glaucoma usally 
starts between 1 and 49 days after starting topiramate therapy 
with 85% of case occuring within the first 2 weeks[11].  
Whenever a case of myopia with angle closure glaucoma and a 
shallow anterior chamber is encountered, ciliochoroidal effusion 
syndrome induced by drugs should be considered in the 
differential diagnosis. Drug induced myopia has also been 
associated with promethazine, spironolactone, tetracycline, 
corticosteroids etc.[7]. Pupils should not be dilated to prevent 
further angle closure and possible rise in pressure. Paediatric and 
developmentally delayed patients who have been started on 
topiramate should be closely monitored during the first 2 weeks 
of treatment.  
CONCLUSION 
This case highlights the development of myopia in a middle 
aged patient with alcohol dependence syndrome while he was 
on topiramate therapy. It is important for the clinician to educate 
the patients about this serious adverse effect while prescribing 
topiramate and advise them to report immediately in the event 
of visual disturbance. 
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